Functional and cross-functional teams expect greater data transparency to make compliance easier, which would mitigate the risk of drug supply gaps. Every day that a drug isn't available costs a ...

Emphasizing the central principles of transparency and bias control, as well as risk-based approaches, the FDA’s guidance underlines the importance of careful data management, documentation ...